Company Encyclopedia
View More
name
MSJK
301507.SZ
Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and health foods in China. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also provides multivitamin, vitamin, and zinc selenium with mineral tablets; glucosamine chondroitin colostrum protein chewable, vitamin soft capsules and chewable, iron folic acid vitamin C, melatonin, coenzyme soft capsules, and calcium magnesium vitamin D tablets; and vitamin C and D3 chewable tablets.
264.22 B
301507.SZMarket value -Rank by Market Cap -/-

Financial Score

21/11/2025 Update
B
Personal Care ProductsIndustry
Industry Ranking10/27
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE7.64%B
    • Profit Margin16.14%A
    • Gross Margin46.90%B
  • Growth ScoreB
    • Revenue YoY20.85%A
    • Net Profit YoY33.21%B
    • Total Assets YoY18.72%A
    • Net Assets YoY13.23%B
  • Cash ScoreB
    • Cash Flow Margin619.67%C
    • OCF YoY20.85%A
  • Operating ScoreC
    • Turnover0.4C
  • Debt ScoreA
    • Gearing Ratio14.92%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Overview of A-share Stock Buybacks: 26 Companies Disclose Buyback Progress Today

    On October 30th, 26 companies announced 27 stock repurchase updates, among which 16 companies disclosed their repurchase plans for the first time, 2 companies' plans were approved by the shareholders' meeting, and 6 companies have completed their repurchases. Hoymiles, SANLUX, and MSJK had the highest repurchase amounts, planning to repurchase RMB 200 million, RMB 60 million, and RMB 50.544 million, respectively. Since the beginning of this year, 1,711 repurchase plans have been implemented, with 330 companies repurchasing over RMB 100 million, and Kweichow Moutai having the highest repurchase amount, reaching RMB 6 billion

    Zhitong·
    SZ
    301507
    -6.59%
    SH
    688032
    -5.03%
    SZ
    002224
    -5.25%
    Zhitong·
    SZ
    301507
    -6.59%
    SH
    688032
    -5.03%
    SZ
    002224
    -5.25%

    MSJK: The market potential of Vaniklan in the domestic market has not been fully developed, and there is significant market potential

    MSJK stated that the potential of varenicline in the domestic market has not been fully developed, and the market size is gradually increasing. The company plans to form a professional team responsible for the marketing of the new smoking cessation product "Lesuoke," which has not yet been officially launched

    Zhitong·
    SZ
    301507
    -6.59%
    Zhitong·
    SZ
    301507
    -6.59%

    MSJK: Net profit of 82.4051 million yuan in the first half of 2025, a year-on-year increase of 6.65%

    In the first half of 2025, MSJK achieved operating revenue of 462 million yuan, a year-on-year increase of 16.37%; net profit was 82.4051 million yuan, a year-on-year increase of 6.65%. The company implemented a product-centric four-new strategy, strengthened product innovation, expanded into the big health sector, integrated probiotic business, and promoted channel ecosystem construction to enhance overall competitiveness

    Zhitong·
    SZ
    301507
    -6.59%
    Zhitong·
    SZ
    301507
    -6.59%

    MSJK: Has repurchased 1.328 million shares, using a total fund amount of 17.2628 million yuan

    On August 4th, MSJK announced that the company has repurchased 1.328 million shares, accounting for 0.37% of the total share capital, with a cumulative expenditure of 17.2628 million yuan. The repurchase price does not exceed 19.8 yuan per share, with an expected repurchase quantity of 1.3 million to 1.45 million shares, and the total repurchase funds are expected to not exceed 28.71 million yuan

    Zhitong·
    SZ
    301507
    -6.59%
    Zhitong·
    SZ
    301507
    -6.59%

    MSJK: The new Minoxidil topical solution is expected to officially hit the market in August

    MSJK stated at an online communication conference that the company's new product, minoxidil topical solution, is expected to officially launch in August, while varenicline tablets are planned to be launched in mid to late September. The company will adopt different sales strategies for these two new products

    Zhitong·
    SZ
    301507
    -6.59%
    Zhitong·
    SZ
    301507
    -6.59%